Fangpeng Shu
- Molecular Biology
- Cancer Research top 5%
- Pulmonary and Respiratory Medicine top 10%
- Immunology
- Oncology
- Co-authors
- Daojun LvRui ZhouQiang SongXumin ZhouXiangming MaoShan‐Chao ZhaoChong WangXian‐Lu Song
- Topics
- Cancer, Hypoxia, and Metabolism (5 papers)Sperm and Testicular Function (4 papers)Ferroptosis and cancer prognosis (4 papers)
- Journals
- SHILAP Revista de lepidopterologíaJournal of Hazardous MaterialsThe Journal of Urology
- Partner nations
- ChinaUnited States
In The Last Decade
Fangpeng Shu
34 papers receiving 880 citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Molecular Biology 497
- Cancer Research 382
- Pulmonary and Respiratory Medicine 238
- Immunology 83
- Oncology 79
Countries citing papers authored by Fangpeng Shu
This map shows the geographic impact of Fangpeng Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangpeng Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangpeng Shu more than expected).
Fields of papers citing papers by Fangpeng Shu
This network shows the impact of papers produced by Fangpeng Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangpeng Shu. The network helps show where Fangpeng Shu may publish in the future.
Co-authorship network of co-authors of Fangpeng Shu
This figure shows the co-authorship network connecting the top 25 collaborators of Fangpeng Shu. A scholar is included among the top collaborators of Fangpeng Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangpeng Shu. Fangpeng Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 5 | |
| 4 | 5 | |
| 5 | 40 | |
| 6 | 9 | |
| 7 | Cuproptosis scoring system to predict the clinical outcome and immune response in bladder cancerbreakdown → | 111 |
| 8 | 78 | |
| 9 | 40 | |
| 10 | 25 | |
| 11 | 20 | |
| 12 | 33 | |
| 13 | 73 | |
| 14 | 5 | |
| 15 | 57 | |
| 16 | 12 | |
| 17 | 16 | |
| 18 | 19 | |
| 19 | 15 | |
| 20 | 52 |
About Fangpeng Shu
Fangpeng Shu is a scholar working on Cancer Research, Reproductive Medicine and Molecular Biology, having authored 35 papers that have together received 889 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (5 papers), Sperm and Testicular Function (4 papers) and Ferroptosis and cancer prognosis (4 papers). The work is most often cited by research in Cancer Research (382 citations), Pulmonary and Respiratory Medicine (238 citations) and Molecular Biology (497 citations). Fangpeng Shu has collaborated with scholars based in China and United States. Frequent co-authors include Daojun Lv, Rui Zhou, Qiang Song, Xumin Zhou, Xiangming Mao, Shan‐Chao Zhao, Chong Wang, Xian‐Lu Song, Wenbin Chen and Taowei Yang. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of Hazardous Materials and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.